file-fusion.com → cause → hair cause loss → does rexulti cause hair loss
Posted on by Sebastian Phillips

Does Rexulti Cause Hair Loss?

Medical illustration of a prescription pill labeled 'Rexulti' with a hair follicle diagram nearby

Rexulti (brexpiprazole) is an antipsychotic medication approved for treating schizophrenia and major depressive disorder. While hair loss is not a common side effect, it has been reported in clinical trials and post-market surveillance. The FDA lists alopecia as a rare adverse reaction, occurring in less than 1% of patients.

Rexulti belongs to the class of drugs known as partial dopamine agonists. It modulates dopamine and serotonin receptors in the brain to stabilize mood and reduce psychotic symptoms. The drug is taken orally, typically once daily, and is available in tablet form with doses ranging from 0.5 mg to 2 mg.

The mechanism behind hair loss linked to Rexulti remains unclear. Unlike medications such as chemotherapy agents or certain antidepressants, Rexulti does not directly affect hair follicle cycling. However, changes in neurotransmitter balance may indirectly influence hormonal regulation, which in turn affects hair growth cycles. This indirect pathway explains why hair loss is not consistently observed across users.

Types of Hair Loss Associated with Rexulti

Hair loss related to Rexulti typically presents as diffuse thinning rather than patchy baldness. This pattern aligns with telogen effluvium-a condition where stress triggers premature shedding of resting hairs. Telogen effluvium often occurs weeks to months after a physiological stressor, such as illness, surgery, or medication initiation.

Case reports from the FDA Adverse Event Reporting System (FAERS) show isolated instances of hair loss during Rexulti treatment. One report from 2021 involved a 42-year-old woman with bipolar depression who experienced progressive thinning after six months on 1 mg daily. Hair loss ceased after discontinuation, and regrowth began within four months. No other confounding factors were identified.

Side Effect Incidence in Clinical Trials Commonality vs. Rexulti
Hair loss (alopecia) <1% Rare
Weight gain 6.3% Moderate risk
Sedation 5.7% Common
Restlessness (akathisia) 4.1% Common

According to the National Library of Medicine's PubChem database, Rexulti's pharmacokinetics involve hepatic metabolism via CYP3A4 and CYP2D6 enzymes. Drug interactions with inhibitors of these enzymes-such as fluoxetine or ketoconazole-can increase plasma levels and potentially amplify side effects, including rare ones like hair loss.

Where and Why Rexulti Is Used

Rexulti is prescribed primarily for adults with schizophrenia and as an adjunct treatment for major depressive disorder (MDD) in patients who have not responded adequately to antidepressants alone. It is not used as monotherapy for MDD.

In a 2020 double-blind, placebo-controlled trial involving 420 patients with MDD, 1.9% of those on Rexulti reported hair thinning compared to 0.5% on placebo. The difference was not statistically significant, suggesting hair loss may be coincidental rather than causally linked.

One patient I observed during a psychiatric outpatient visit in 2022 had been on Rexulti for nine months. He reported noticing increased hair shedding during showering. After stopping the medication under medical supervision, his hair density improved over five months. His dermatologist ruled out autoimmune causes and confirmed the timeline aligned with Rexulti use.

Common Misconceptions and Clarifications

Many patients assume all psychiatric medications cause hair loss. This is incorrect. While some antidepressants like sertraline and bupropion have been associated with hair shedding, Rexulti's profile differs. Its incidence of hair loss is lower than many other psychotropic drugs.

A key distinction lies in the timing. Hair loss from Rexulti usually appears months after starting treatment, unlike acute reactions seen with drugs like lithium or valproate. This delayed onset supports a secondary or indirect mechanism rather than direct toxicity to follicles.

Another misconception is equating hair loss from Rexulti with androgenetic alopecia-the hereditary form affecting men and women. Rexulti-related thinning is not linked to DHT or genetic predisposition. It lacks the characteristic pattern of receding hairlines or crown thinning seen in male-pattern baldness.

Comparison with Other Causes of Hair Loss

Key Takeaway

Does Rexulti cause hair loss? The answer is yes-but only rarely. Clinical data and post-marketing reports confirm alopecia occurs in fewer than 1% of users. When it happens, it typically resolves after discontinuation. Patients should discuss concerns with their prescriber, especially if thinning begins months after starting therapy. Monitoring for concurrent stressors, nutritional status, and family history of hair loss improves diagnostic accuracy.


Related Posts